Pilotstudy about endocrinilogical, peripherphysilogical and painreducing effects of Gamma-hydroxybutyrate in combination with operant-behaviour-therapeutic paintherapy with patients in Fibromyalgia-Syndrome - GHB and OVT with patients in Fibromyalgia (FMS)
- Conditions
- Patients with Fibromyalgia-syndrome
- Registration Number
- EUCTR2005-002475-32-DE
- Lead Sponsor
- Charitè Universitätmeditin Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
ACR-criteria of Fibromalgia-Syndrome
female
Age 18-80
containment of german language
motivation of therapy
written acceptance of the patient
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
gravidity
psychiatric-diseased person
taking sedated drugs (including opiate)
desire of pension
persons under 18 and over 80 years
persons, who are unable to consent
instable arterial hypertension
epilepsy
seriously interference of renal function
alcoholintoxication
taking opiate
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method